BLKB

Analyst Note: Blackbaud, Inc. (BLKB)

Date: 2026-06-13 Current Price: $27.04

1. Structural Readiness

State: Forming Aggressive/Pre-Breakout Entry: N/A (Current price is within the consolidation range, not a confirmed breakout entry) Breakout Level: Pending confirmation. Current Price: $27.04 Extension: N/A (Price is not extended above a breakout level; it is in the consolidation phase). ATR Context: Current ATR is 6.3% (Very High). This elevated volatility suggests the market is pricing in significant uncertainty or active re-rating, which complicates the definition of a tight structural stop until a clear breakout occurs.

2. Thesis Layer

Thesis Status: Tactical / Setup-Led Macro Thesis: None named at this date. Analysis: As of June 13, 2026, Blackbaud is not being analyzed through a specific secular macro lens (e.g., "AI Supercycle" or "Nonprofit Recession Play"). The investment case is strictly tactical, driven by the quality of the technical setup (the forming coil) and the fundamental inflection points disclosed by management in the recent earnings cycle. The conviction relies on the execution of the "Margin Inflector" archetype rather than a broad market tailwind.

3. Business Overview

Company: Blackbaud, Inc. Industry: Technology / Software (SaaS) Sector: Technology Business Model: Blackbaud operates as a leading provider of cloud-based software solutions for the social impact sector (nonprofits, educational institutions, and CSR-focused companies). The company generates revenue primarily through annual subscription fees and payment processing services.

Key Fundamentals & Evidence (as of 2026-06-13):

• Product Portfolio: The company offers a comprehensive suite including "Raiser's Edge NXT" (fundraising), "Luminate Online" (marketing), and "Blackbaud AI Chat" (launched late 2025). They also provide "Agents For Good," an agentic AI solution launched in Q1 2026, priced in the "tens of thousands per year" with plans to cross-sell to thousands of existing customers.
• Revenue Visibility: As of March 31, 2026, the company has approximately $1.4 billion in remaining performance obligations (RPO). Management expects to recognize 45% of these over the next 12 months.
• Contract Quality: Renewal dynamics are strengthening. More than 20% of renewing customers have elected four-year or longer contracts, with an increasing number requesting five-year terms.
• Retention: Gross dollar retention for the twelve months ended March 31, 2026, was approximately 92%.
• AI Integration: Over half of "Raiser's Edge NXT" customers utilize machine learning-enabled donor prospecting, generating nearly 30 billion predictions annually.
• Capital Allocation: Management intends to repurchase between 5.0% and 10.0% of outstanding common stock during 2026.

4. Archetype and Conviction Stack

Archetype: Margin Inflector Fit Analysis: The company fits the "Margin Inflector" archetype based on management's explicit guidance to expand Adjusted EBITDA margins to 40% plus while growing Adjusted EBITDA at 6% to 8% annually.

• Growth vs. Margin Trade-off: Management acknowledges a near-term headwind, noting that Adjusted EBITDA dollars may decline slightly in Q2 2026 due to planned AI investments for customer-facing products and internal operations. However, the long-term target (2026–2030) is double-digit annual EPS growth driven by 4–6% organic revenue growth and margin expansion.
• Valuation Context: The financial spine indicates a Forward Consensus EPS of $5.1975 for FY1 and $5.9425 for FY2. At a current price of $27.04, the stock trades at approximately 5.2x FY1 EPS and 4.5x FY2 EPS. This valuation compression relative to the stated double-digit EPS growth targets suggests the market is currently pricing in the near-term margin compression (AI capex) rather than the long-term inflection.
• Conviction Stack:
• *Thesis Strength:* Moderate (Tactical, no macro tailwind).
• *Evidence Quality:* High (Strong RPO visibility, clear margin targets, high retention).
• *Structural Quality:* Moderate (Forming coil, high volatility).
• *Rerating Potential:* High (If the market re-rates the stock from a "margin compression" narrative to a "margin inflection" narrative, the multiple could expand significantly).

5. Invalidations, Strengths, and Gaps

What Would Strengthen the Case:

• Margin Expansion Acceleration: Management revising guidance to show EBITDA margin expansion occurring sooner than the 2026–2030 horizon, or Q2 EBITDA dollars beating the "slight decline" expectation.
• Agent Adoption: Public disclosure of significant "Agent For Good" adoption rates or pricing power realization (e.g., moving from "tens of thousands" to higher tiers).

What Would Invalidate the Case:

• Retention Deterioration: A drop in Gross Dollar Retention significantly below the 92% level reported in Q1 2026.
• Guidance Cut: Management reducing the long-term EPS growth targets or the 40%+ EBITDA margin target.

Evidence Gaps:

• AI ROI Timeline: While AI investments are noted as a near-term drag, the specific timeline for when these investments will translate into the "double-digit EPS growth" is qualitative ("potential upside based on viral events") rather than a precise quantitative roadmap.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: Management targets 40%+ EBITDA margins and double-digit EPS growth 2026-2030; $1.4B RPO provides revenue visibility; 92% gross dollar retention and 20%+ of renewals on 4+ year contracts. Key risks: Near-term EBITDA decline due to AI capex; high current ATR (6.3%) indicates elevated volatility and potential for false breakouts; lack of named secular thesis limits macro tailwinds. Expected path: Management executes on AI investments, EBITDA margins expand to 40%+, and the stock breaks out of the consolidation range to re-rate on the margin inflection narrative. Expected horizon: 6 to 12 months for the margin inflection to become visible in earnings and for the technical setup to resolve.